Compound Detail
CHEMBL489967
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL489967 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | BBZGOLNDVQZCIH-UHFFFAOYSA-N |
6
Targets
7
Activities
2
Assay Types
0
PK Parameters
15
Publications
0
Known Names
Molecular Properties
351.4
MW (Da)
4.03
ALogP
5
HBA
2
HBD
73.9
PSA (Ų)
0.73
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 5 meas. best 7.05
EC50 2 meas. best 6.58
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | IC50 | 7.05 | 7.05 | 90.0 | 1 |
| Human immunodeficiency virus 1 CHEMBL378 | EC50 | 6.58 | 6.58 | 260.0 | 2 |
| CEM-SS CHEMBL614548 | IC50 | 6.18 | 6.18 | 660.0 | 1 |
| Cyclin-dependent kinase 5/CDK5 activator 1 CHEMBL1907600 | IC50 | 5.77 | 5.77 | 1700.0 | 1 |
| Glycogen synthase kinase-3 CHEMBL2366565 | IC50 | 5.29 | 5.29 | 5100.0 | 1 |
| Dual specificity protein kinase CLK1 CHEMBL1075280 | IC50 | 5.07 | 5.07 | 8500.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | IC50 | = | 90.0 | nM | 7.05 | Inhibition of starfish oocyte CDK1/cyclin B using [gamma 33P]ATP after 30 mins b... | 22352892 |
| Human immunodeficiency virus 1 | EC50 | = | 260.0 | nM | 6.58 | Antiviral activity against HIV1 RF in human CEM-SS cells assessed as inhibition ... | 11430019 |
| Human immunodeficiency virus 1 | EC50 | = | 260.0 | nM | 6.58 | Antiviral activity against HIV1 in human CEM-SS cells after 6 days | 1624941 |
| CEM-SS | IC50 | = | 660.0 | nM | 6.18 | Cytotoxicity against human CEM-SS cells | 1624941 |
| Cyclin-dependent kinase 5/CDK5 activator 1 | IC50 | = | 1700.0 | nM | 5.77 | Inhibition of human recombinant CDK5/p25 using [gamma 33P]ATP after 30 mins by s... | 22352892 |
| Glycogen synthase kinase-3 | IC50 | = | 5100.0 | nM | 5.29 | Inhibition of porcine brain GSK3alpha/beta using GS1 as substrate | 22352892 |
| Dual specificity protein kinase CLK1 | IC50 | = | 8500.0 | nM | 5.07 | Inhibition of GST-tagged mouse recombinant CLK1 expressed in Escherichia coli us... | 22352892 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 1624941 | 10.1021/np50080a008 | Human immunodeficiency virus 1 | 4 |
| 1624941 | 10.1021/np50080a008 | Escherichia coli | 2 |
| 11430019 | 10.1021/np0003995 | Human immunodeficiency virus 1 | 1 |
| 11430019 | 10.1021/np0003995 | ADMET | 1 |
| 1624941 | 10.1021/np50080a008 | CEM-SS | 1 |
| 1624941 | 10.1021/np50080a008 | Human immunodeficiency virus 2 | 1 |
| 1624941 | 10.1021/np50080a008 | Human immunodeficiency virus type 1 reverse transcriptase | 1 |
| 1624941 | 10.1021/np50080a008 | Unchecked | 1 |
| 1624941 | 10.1021/np50080a008 | Protease | 1 |
| 1624941 | 10.1021/np50080a008 | NON-PROTEIN TARGET | 1 |
| 22352892 | 10.1021/jm201727w | Cyclin-dependent kinase 5/CDK5 activator 1 | 1 |
| 22352892 | 10.1021/jm201727w | Glycogen synthase kinase-3 | 1 |
| 22352892 | 10.1021/jm201727w | Dual specificity protein kinase CLK1 | 1 |
| 22352892 | 10.1021/jm201727w | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 1 |
| 22352892 | 10.1021/jm201727w | Unchecked | 1 |
Data from ChEMBL 36 via Core Engine